Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial

被引：0
|
作者：
Christine Lundgren
Julia Tutzauer
Sarah E. Church
Olle Stål
Maria Ekholm
Carina Forsare
Bo Nordenskjöld
Mårten Fernö
Pär-Ola Bendahl
Lisa Rydén
机构：
[1] Region Jönköping County,Department of Oncology
[2] Linköping University,Department of Biomedical and Clinical Sciences
[3] Lund University,Division of Oncology, Department of Clinical Sciences Lund
[4] NanoString Technologies,Division of Surgery, Department of Clinical Sciences Lund
[5] Inc.,Department of Surgery
[6] Lund University,undefined
[7] Skåne University Hospital,undefined
来源：
Breast Cancer Research | / 25卷
关键词：
Gene expression signatures; Premenopausal; Tamoxifen; Prognostic; Predictive;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting
    Wu, Ziping
    Xu, Shuguang
    Zhou, Liheng
    Yin, Wenjin
    Lin, Yanpin
    Du, Yueyao
    Wang, Yaohui
    Jiang, Yiwei
    Yin, Kai
    Zhang, Jie
    Lu, Jinsong
    ONCOTARGETS AND THERAPY, 2018, 11 : 801 - 808
  • [32] Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - A randomized trial from the South Sweden Breast Cancer Group
    Killander, Fredrika
    Anderson, Harald
    Ryden, Stefan
    Moller, Torgil
    Hafstrom, L. O.
    Malmstrom, Per
    BREAST, 2009, 18 (05) : 309 - 315
  • [33] CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen
    Jean E Abraham
    Mel J Maranian
    Kristy E Driver
    Radka Platte
    Bolot Kalmyrzaev
    Caroline Baynes
    Craig Luccarini
    Mitul Shah
    Susan Ingle
    David Greenberg
    Helena M Earl
    Alison M Dunning
    Paul DP Pharoah
    Carlos Caldas
    Breast Cancer Research, 12
  • [34] Long-Term Health Outcomes of a Decision Aid: Data from a Randomized Trial of Adjuvant! in Women with Localized Breast Cancer
    Vickers, Andrew J.
    Elkin, Elena B.
    Peele, Pamela B.
    Dickler, Maura
    Siminoff, Laura A.
    MEDICAL DECISION MAKING, 2009, 29 (04) : 461 - 467
  • [35] Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98
    Alkner, S.
    Jensen, M. -B.
    Rasmussen, B. B.
    Bendahl, P. -O.
    Ferno, M.
    Ryden, L.
    Mouridsen, H.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (02) : 481 - 490
  • [36] Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98
    S. Alkner
    M.-B. Jensen
    B. B. Rasmussen
    P.-O. Bendahl
    M. Fernö
    L. Rydén
    H. Mouridsen
    Breast Cancer Research and Treatment, 2017, 166 : 481 - 490
  • [37] Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men Results from the MALE Phase 2 Randomized Clinical Trial
    Reinisch, Mattea
    Seiler, Sabine
    Hauzenberger, Tanja
    Kamischke, Axel
    Schmatloch, Sabine
    Strittmatter, Hans-Joachim
    Zahm, Dirk-Michael
    Thode, Christian
    Furlanetto, Jenny
    Strik, Dominika
    Mobus, Volker
    Reimer, Toralf
    Sinn, Bruno Valentin
    Stickeler, Elmar
    Marme, Frederik
    Janni, Wolfgang
    Schmidt, Marcus
    Rudlowski, Christian
    Untch, Michael
    Nekljudova, Valentina
    Loibl, Sibylle
    JAMA ONCOLOGY, 2021, 7 (04) : 565 - 572
  • [38] Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer
    Ewa E. Hennig
    Magdalena Piatkowska
    Jakub Karczmarski
    Krzysztof Goryca
    Elzbieta Brewczynska
    Radoslaw Jazwiec
    Anna Kluska
    Robert Omiotek
    Agnieszka Paziewska
    Michal Dadlez
    Jerzy Ostrowski
    BMC Cancer, 15
  • [39] Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer
    Hennig, Ewa E.
    Piatkowska, Magdalena
    Karczmarski, Jakub
    Goryca, Krzysztof
    Brewczynska, Elzbieta
    Jazwiec, Radoslaw
    Kluska, Anna
    Omiotek, Robert
    Paziewska, Agnieszka
    Dadlez, Michal
    Ostrowski, Jerzy
    BMC CANCER, 2015, 15
  • [40] Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel
    Mendiola, Marta
    Martinez-Marin, Virginia
    Herranz, Jesus
    Heredia, Victoria
    Yebenes, Laura
    Zamora, Pilar
    Castelo, Beatriz
    Pinto, Alvaro
    Miguel, Maria
    Diaz, Esther
    Gamez, Angelo
    Fresno, Juan Angel
    Ramirez de Molina, Ana
    Hardisson, David
    Espinosa, Enrique
    Redondo, Andres
    ONCOTARGET, 2016, 7 (17) : 24217 - 24227
12345